The Ethics of Gene Therapy for Sickle Cell Disease

By sjmartinez • April 23, 2025

Patel A, Kuo A. The Ethics of Gene Therapy for Sickle Cell Disease. Cureus. 2025 Mar 23;17(3):e81037. doi: 10.7759/cureus.81037. PMID: 40264617; PMCID: PMC12013961.

Tags: ethic consideration, Gene therapy, General Internal Medicine, informed consent, Med Peds, neurocognitive impairment, Publications, SCD, sickle cell disease

Donna L. Washington, MD, MPH, FACP Appointed Section Chief of General Internal Medicine at the VA Greater Los Angeles Healthcare System

It is with great pleasure that we announce the appointment of Donna L. Washington, MD, MPH, FACP as the incoming section chief of General Internal Medicine at[...]

Effect of Language Interpreter Modalities on Patient Satisfaction and Clinical Workflow: A Pilot Study in a Multidisciplinary Pediatric Craniofacial Clinic

Juang S, Nguyen S, Osman N, Ghodrati K, Reyes C, Maldonado I, Pino J, Duarte M, Halley K, Hendrickson I, Tu M, Peralta JB, Wilhalme[...]

Reframing Opioid Overdose as an Ambulatory Care-Sensitive Condition

Hsu M, Lawrence D, Capone-Newton P, Gelberg L. Reframing Opioid Overdose as an Ambulatory Care-Sensitive Condition. JAMA. 2025 Dec 29. doi: 10.1001/jama.2025.23741. Epub ahead of[...]